Results 21 to 30 of about 1,588,451 (244)

PD-L1 sensitivity and specificity of antibody clone 29E.2A3 for PD-L1.

open access: yes, 2021
A.Western blot of cell lysates from cultured human breast cancer cell lines known to express (MDA-MB-231) or not to express PD-L1 (MCF-7) using E1L3N Rabbit mAb, confirming the PD-L1 status of these two cell lines. B.
James M. Rae (7876037)   +15 more
core   +1 more source

The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. [PDF]

open access: yes, 2012
The balance between pro-inflammatory and regulatory immune responses in determining optimal T cell activation is vital for the successful resolution of microbial infections.
Couper, Kevin N   +44 more
core   +1 more source

Western Blot PD-L1 expression after XVir-N-31-anti-PD-L1 infection.pdf

open access: yes, 2022
PD-L1 expression of HEK cells after XVir-N-31-anti-PD-L1 infection.
Moritz Klawitter (13177230)
core   +1 more source

Binding and inhibition assays of anti-PD-L1 antibody.

open access: yes, 2022
(A) Specific binding to human PD-L1 by ELISA. The Tecentriq® and human IgG1 was used as positive and negative control respectively. Plant-produced anti-PD-1 antibody was also used to confirm the non-specificity to PD-L1.
Thareeya Phetphoung (14106521)   +11 more
core   +1 more source

Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration

open access: yesFrontiers in Cell and Developmental Biology, 2021
Programmed cell death ligand 1 (PD-L1) is widely expressed in a variety of human tumors, and inhibition of the PD-L1/PD-1 pathway represents one of the most promising therapy for many types of cancer.
Ruirui Wang   +8 more
doaj   +1 more source

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer

open access: yesFrontiers in Immunology, 2022
The immune checkpoint pathway consisting of the cell membrane-bound molecule programmed death protein 1 (PD-1) and its ligand PD-L1 has been found to mediate negative regulatory signals that effectively inhibit T-cell proliferation and function and ...
Mengke Niu   +5 more
doaj   +1 more source

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

open access: yesCell & Bioscience, 2018
Antibody blockade of the PD-1/PD-L1 pathway has elicited durable antitumor responses in the therapy of a broad spectrum of cancers. PD-L1 is constitutively expressed in certain tumors and host immune cells, and its expression can be induced or maintained
Fei Tang, Pan Zheng
doaj   +1 more source

PD-L1 blockade after XVir-N-31-anti-PD-L1 infection.pzfx

open access: yes, 2022
PD-L1 blockade assay 
Moritz Klawitter (13177230)
core   +1 more source

Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients

open access: yesJournal of the Egyptian National Cancer Institute, 2018
Cancer immunotherapy targeting programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway has shown promising results in treatment of non-small cell lung cancer (NSCLC) patients.
Dina M. El-Guindy   +3 more
doaj   +1 more source

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma

open access: yesDiagnostics, 2020
Recent data have suggested that PD-1 and PD-L1 are involved in osteosarcoma (OS) pathogenesis; however, their contributions are not well-established. Here, the PD-1/PD-L1 expression was evaluated in (OS) cases.
Kazuhiko Hashimoto   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy